Klamova H - Search Results

1

Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic.

Klamova H, Faber E, Zackova D, Markova M, Voglova J, Cmunt E, Novakova L, Machova-Polakova K, Moravcova J, Dvorakova D, Michalova K, Brezinova J, Oltova A, Jarosova M, Cetkovsky P, Indrak K, Mayer J. Klamova H, et al. Neoplasma. 2010;57(4):355-9. Neoplasma. 2010. PMID: 20429627

2

A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene.

Polák J, Zemanová Z, Michalová K, Klamová H, Cermák J, Haskovec C. Polák J, et al. Among authors: klamova h. Leukemia. 1998 Feb;12(2):250. doi: 10.1038/sj.leu.2400913. Leukemia. 1998. PMID: 9519792 No abstract available.

3

[Interferon alpha--the drug of choice for patients with chronic myeloid leukemia].

Klamová H, Vítek A, Michalová K, Brezinová J, Moravcová J, Jelínek J, Cermák J. Klamová H, et al. Cas Lek Cesk. 1998 Sep 21;137(18):552-6. Cas Lek Cesk. 1998. PMID: 9818464 Czech.

4

P230 BCR/ABL protein may be associated with an acute leukaemia phenotype.

Haskovec C, Ponzetto C, Polák J, Maritano D, Zemanová Z, Serra A, Michalová K, Klamová H, Cermák J, Saglio G. Haskovec C, et al. Among authors: klamova h. Br J Haematol. 1998 Dec;103(4):1104-8. doi: 10.1046/j.1365-2141.1998.01098.x. Br J Haematol. 1998. PMID: 9886327 Free article.

5

To the incidence of nucleoli in circulating myeloblasts of patients suffering from acute myeloblastic, promyelocytic and myelomonocytic leukemias.

Smetana K, Subrtová H, Jirásková I, Klamová H, Lemez P, Rosa L. Smetana K, et al. Among authors: klamova h. Neoplasma. 1998;45(5):277-81. Neoplasma. 1998. PMID: 9921915

6

Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse.

Moravcová J, Muchová S, Lukásová M, Klamová H, Brezinová J, Gasová Z. Moravcová J, et al. Among authors: klamova h. Bone Marrow Transplant. 1999 Apr;23(8):857-9. doi: 10.1038/sj.bmt.1701663. Bone Marrow Transplant. 1999. PMID: 10231156 No abstract available.

7

Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.

Moravcová J, Nádvorníková S, Lukásová M, Klamová H. Moravcová J, et al. Among authors: klamova h. Blood. 1999 Nov 15;94(10):3609-11. Blood. 1999. PMID: 10610116 Free article. No abstract available.

8

A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of action.

Smetana K, Jirásková I, Klamová H. Smetana K, et al. Among authors: klamova h. Neoplasma. 1999;46(5):295-8. Neoplasma. 1999. PMID: 10665845

9

[Imatinib mesylate (Glivec) in treatment of chronic phase chronic myeloid leukemia].

Voglová J, Poznarová A, Chrobák L, Rabasová J, Beránek M, Moravcová J, Faber E, Klamová H, Cikhart M. Voglová J, et al. Among authors: klamova h. Vnitr Lek. 2004 Jan;50(1):21-3, 26-9. Vnitr Lek. 2004. PMID: 15015226 Clinical Trial. Czech.

10

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.

Moravcová J, Zmeková V, Klamová H, Voglová J, Faber E, Michalová K, Rabasová J, Jarosová M. Moravcová J, et al. Among authors: klamova h. Leuk Res. 2004 Apr;28(4):415-9. doi: 10.1016/j.leukres.2003.08.002. Leuk Res. 2004. PMID: 15109543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters